| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |